Qube Research & Technologies LTD Vanda Pharmaceuticals Inc. Transaction History
Qube Research & Technologies LTD
- $72.9 Billion
- Q4 2024
A detailed history of Qube Research & Technologies LTD transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 27,481 shares of VNDA stock, worth $121,466. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,481Holding current value
$121,466% of portfolio
0.0%Shares
14 transactions
Others Institutions Holding VNDA
# of Institutions
154Shares Held
43.8MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$36 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$17 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$15.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$10.4 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $250M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...